Loading…

Hypermethylation of Hepatic Glucokinase and L-Type Pyruvate Kinase Promoters in High-Fat Diet–Induced Obese Rats

DNA hypermethylation is correlated with a decline in hepatic glucokinase and L-type pyruvate kinase expression in high-fat diet-induced obese rats. Obesity-dependent insulin resistance and type 2 diabetes mellitus are closely associated with decreased glucose utilization and down-regulation of hepat...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology (Philadelphia) 2011-04, Vol.152 (4), p.1284-1289
Main Authors: Jiang, Minghong, Zhang, Yuhao, Liu, Meng, Lan, Michael Shihli, Fei, Jing, Fan, Weiwei, Gao, Xin, Lu, Daru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:DNA hypermethylation is correlated with a decline in hepatic glucokinase and L-type pyruvate kinase expression in high-fat diet-induced obese rats. Obesity-dependent insulin resistance and type 2 diabetes mellitus are closely associated with decreased glucose utilization and down-regulation of hepatic glycolytic enzymes expression. Previously, we showed that DNA hypermethylation is involved in age-dependent susceptibility to hepatic insulin resistance and diabetes. However, what we cannot distinguish is whether the age-related obesity contributes to DNA hypermethylation in those natural aging rats. In the present study, we hypothesize that DNA methylation plays a crucial role in the regulation of glycolytic enzymes in the high-fat diet–induced obesity. Here, we report that DNA hypermethylation is correlated with a decline in hepatic glucokinase (Gck) and L-type pyruvate kinase (LPK) expression in high-fat diet–induced obese rats as compared with the control diet group. Down-regulation of Gck and LPK expression are reversed by the 5-aza-2′-deoxycytidine in the cell model of steatosis. These novel observations indicate that DNA methylation is involved in the development of metabolic diseases, such as obesity, insulin resistance, type 2 diabetes mellitus, and nonalcoholic steatohepatitis, suggesting that the hypermethylation level of Gck and LPK promoters may be a useful parameter for the evaluation of obesity-induced insulin resistance and fatty liver.
ISSN:0013-7227
1945-7170
DOI:10.1210/en.2010-1162